Background: In 2011-2012, Northern Vietnam experienced its first large scale hand foot and mouth disease (HFMD) epidemic. In 2011, a major HFMD epidemic was also reported in South Vietnam with fatal cases. This 2011-2012 outbreak was the first one to occur in North Vietnam providing grounds to study the etiology, origin and dynamic of the disease. We report here the analysis of the VP1 gene of strains isolated throughout North Vietnam during the 2011-2012 outbreak and before. Methods: The VP1 gene of 106 EV-A71 isolates from North Vietnam and 2 from Central Vietnam were sequenced. Sequence alignments were analyzed at the nucleic acid and protein level. Gene polymorphism was also analyzed. A Factorial Correspondence Analysis was performed to correlate amino acid mutations with clinical parameters. Results: The sequences were distributed into four phylogenetic clusters. Three clusters corresponded to the subgenogroup C4 and the last one corresponded to the subgenogroup C5. Each cluster displayed different polymorphism characteristics. Proteins were highly conserved but three sites bearing only Isoleucine (I) or Valine (V) were characterized. The isoleucine/valine variability matched the clusters. Spatiotemporal analysis of the I/V variants showed that all variants which emerged in 2011 and then in 2012 were not the same but were all present in the region prior to the 2011-2012 outbreak. Some correlation was found between certain I/V variants and ethnicity and severity. Conclusions: The 2011-2012 outbreak was not caused by an exogenous strain coming from South Vietnam or elsewhere but by strains already present and circulating at low level in North Vietnam. However, what triggered the outbreak remains unclear. A selective pressure is applied on I/V variants which matches the genetic clusters. I/V variants were shown on other viruses to correlate with pathogenicity. This should be investigated in EV-A71. I/V variants are an easy and efficient way to survey and identify circulating EV-A71 strains.
Background
Hand, foot and mouth disease (HFMD) is an acute febrile illness in children with a papulovesicular skin rash at the palms or soles of the feet, or both. Presentation can be with or without inclusion of mouth ulcers. Although the disease is usually mild and self-limiting, in some cases HFMD can result in severe complications such as encephalitis, aseptic meningitis, pulmonary edema, myocarditis, and death [29] . HFMD is caused by members of Human Enterovirus A, a family of picornaviridae which includes Coxsackievirus A (CV-A) and Human Enterovirus 71 (EV-A71) [3, 7] . The EV-A71 viruses are genetically related to CV-A; indeed, it has been suggested that these viruses may have diverged as recently as the 1940s [27] . Both EV-A71 and CV-A infections have been associated with severe HFMD in young children, sometimes resulting in death [2, 21, 33] .
Enteroviruses are characterized by the presence of 4 structural proteins, VP4 being the internal capsid protein and VP1, VP2 and VP3 making the three external capsid proteins [6] . VP1 is the most external and is the main component of the canyon on the surface of picornaviruses. VP1 is involved in viral pathogenicity, receptor binding and immune modulation of EV-A71 [13, 31] . Differences in EV-A71 strains might contribute to the different severity of the disease [18, 24] and virulence determinants have been identified in the VP1 protein such as residues G/Q/R at position VP1-145, E at VP1-164 [5, 12, 16] . VP1 is used to classify enteroviruses. Based on the VP1 gene, EV-A71 is classified into three independent genogroups: A, B, and C. The EV-A71 B and C genogroups are each further subdivided into five subgenogoups, B1 to B5 and C1 to C5 [4] .
Although EV-A71 was isolated for the first time in Vietnam in 2003, the first outbreak of HFMD was not reported in the southern provinces until 2005. The 2005 outbreak was associated with EV-A71 C1, C4 and C5 genotypes and Coxsackievirus A16 [14, 28] . In 2011, a major HFMD epidemic was reported in South Vietnam with fatal cases reported [19] . This 2011-2012 outbreak was the first one to occur in North Vietnam providing grounds to study the etiology, origin and dynamic of the disease. We report here the analysis of the VP1 gene of strains isolated throughout North Vietnam during the 2011-2012 outbreak.
Methods

Epidemiological information and source of specimens
All HFMD cases in Northern provinces were reported to the National Institute of Hygiene and Epidemiology (NIHE) through the national communicable disease surveillance system since 2011. HFMD patients that reported to health centers or hospitals were diagnosed and classified in 4 severity levels (Additional file 1: Table S1 ).
The evaluation of the disease was performed according to the guidelines specifically published by the Vietnamese Ministry of Health which are based on WHO and Taiwanese guidelines [11, 29] (Table 1 ). All samples were sent to the Enterovirus Laboratory of NIHE for etiological assays. Enteroviruspositive and EV-A71-positive samples were identified according to Nix et al. [20] using SO (SO224/SO222), AN (AN88/AN89) and MAS (MAS01S/MAS02A) [22] primer sets. Viral RNA was directly extracted from throat swab using QIAamp® Viral RNA Mini Kit (Qiagen, Valencia, USA). The cDNA was prepared using the GoScript™ Reverse Transcriptase kit from Promega. Seminested RT-PCR was conducted as described by Nix et al. [20] . The cDNA was first synthesized from the RNA for 10 min at 25°C and followed by synthesis of the second strand at 42°C for 50 min, 72°C for 15 min using primers AN32, AN33, AN34 and AN35 [20] . PCR was done as described by Nix et al. [20] with 40 cycles of amplification (95°C for 30 s, 42°C for 30 s and, 60°C for 45 s). One microliter of the first PCR was used a second seminested amplification for 40 amplification cycles of 95°C for 30 s, 60°C for 20 s, and 72°C for 15 s. Sequencing was performed with the Sanger method using the is Bigdye Terminator V3.1 cycle sequencing kit from Applied Biosystems in an ABI sequencer 3130.
Sequence analyses
Sequences were deposited in GenBank and accession numbers are provided in Table 1 . The VP1 genetic sequences were aligned in Seaview 4.6 [10] using Muscle algorithm [9] . Best-fitting evolutionary models were determined by JModelTest 2.1 [8] or by ProtTest 2.4 [1] using the corrected version of the Akaike Information Criterion (AICc). The phylogeny of VP1 was performed by Maximum Likelihood (ML) inference using the model GTR + G + F with Seaview 4.6 [10] . The robustness of nodes was assessed with 500 bootstrap replicates. ML analysis of the amino acid sequences was performed using the model JTT + I + G with Seaview 4.6 [10] . The robustness of nodes was assessed with 500 bootstrap replicates. Sequence polymorphism was investigated using the DnaSP 5.10.01 package [17] . Amino acid numbering was done with respect to full length polyprotein using the sequence HQ129932.1 [16] as a reference.
Bias and ethics
Training session on HFMD cases definition and reporting were organized for the staff of the routine surveillance system to enhance quality and consistency of case report. This work was conducted following the requirements of the Vietnamese Ministry of Health and under the Law of Communicable Diseases Prevention and Control passed in 2007.
Factorial correspondence analysis
A factorial correspondence analysis (FCA) was performed using XLSTAT software (Addinsoft® 
Results
Clinical and epidemiological features
Data are shown in Table 1 . Patients age ranged from 2 months to 12 years old (median at 1.8 years, IQR of 1.5 years). 102/106 (96.23%) patients were under 5. The age-specific incidence highest in the 1-2 years age group (44 cases, 41.51%) and remained very low for older children. The lowest incidence was observed in infants under 6 months (2.83%) and children above 10 years old (0.94%). Patients came from all parts of the region including mountainous, rural and urban areas. Out of 83 Table S1 g) "0" means that admission occurred the same day as onset cases, 59 (71.08%) belonged to main Vietnamese ethnicity (Ethnicity 1) while the rest of patients belonged to the minority Hmong ethnicity (Ethnicity 2) ( 
VP1 phylogeny and population structure
Phylogenetic analysis of the VP1 gene sequences indicated the presence of four clusters (Fig. 1) . Cluster 1, the closest to the root, was the main one, comprising 56 sequences and structured into several subclusters characterized by low bootstrap values. Cluster 2 and cluster 3 comprised respectively 23 and 12 sequences and segregated from cluster 1 to which they were separated with a low bootstrap of 30. The last cluster, cluster 4, comprising 17 sequences was characterized by a high bootstrap value (100) and was a derivate from cluster 3. A similar tree topology was observed when using protein alignments (Data not shown). With respect to the current genogroup classification, clusters 1, 2 and 3 belonged to the subgenogroup C4 whereas cluster 4 belonged to the subgenogroup C5 (Table 1 ). The VP1 protein was characterized by a high rate of conservation. However, three sites displayed a consistent Valine (V) / Isoleucine (I) variation (Fig. 2) . These sites, sites A, B and C were located in the VP1 protein at position 814, 827 and 849 of the polyprotein. Six types of I/V variants were observed when considering the amino acids at sites A, B and C: VVI (1 sequence), IVI (15 sequences), IIV (28 sequences), VII (38 sequences), VIV (23 sequences) and VVV (3 sequences) ( Table 1) . When attributing a color code for each I/V variant population and applying it to the phylogenetic tree a clear overlap with the previously detected clusters was observed (Fig. 1) . Cluster 4 overlapped with the IVI population while clusters 2 and 3 comprised the VII variants. The VVV, IVV and VIV variants all corresponded to cluster 1. However they did not mix and each one corresponded to a specific subcluster. The VVI variant derived from the cluster 4 / IVI group. Three exceptions were found, with VII variants present in clusters 1 and 4. With respect to phylogeny, the I/V variant closest to the root is VVV, the VIV population emerged from this group and gave rise in turn to the IIV group. The VII groups, derived from the VIV group with first cluster 2 from which cluster 3 evolved. The well separated cluster 4/IVI variants evolved from cluster 3. This overlap between clusters and I/V populations was even stronger at the protein level since almost all the variability was borne by the I/V mutations, the rest of the protein being highly conserved. Groups VII, IIV, VVV and VIV belonged to the subgenogroup C4 whereas groups IVI and VVI belonged to the subgenogroup C5.
Nucleic acid polymorphism
When considering the polymorphism of the various clusters identified, very different traits were observed ( Table 2) . Cluster 1 was polymorphic (θ = 14.58) but with a 2.5 times more parsimony informative sites than singletons and 10-times more synonymous mutations than non-synonymous ones, suggesting that it is not a recent polymorphism or expanding population. The Ka/ Ks ratio was also characterized by a low value. Conversely, cluster 2 displayed a very low level of polymorphism with a q of 4.06 and a low number of mutations η (η = 15). The Ka/Ks was slightly higher at 0.107. This is suggesting the existence of a bottleneck at the origin of cluster 2. Cluster 3 which originated from cluster 2 was more polymorphic with a slightly increasing θ (θ = 6.92) and number of mutations η (η = 19). Only synonymous mutations were observed resulting in turn in a very low Ka/Ks ratio of 0.029. Cluster 4 was on the other hand displaying a very high polymorphism with a η of 113 for 109 and a very high level of synonymous mutations (105 out of 110) suggesting a strong negative selection acting on a mutating population. As a consequence, the Ka/Ks ratio was also very low at 0.011.
Distribution of mutations and correlation analysis
The correlation analysis indicated a partial structuration of cases (34% of dispersion explained) on different parameters (Fig. 3) . The VVI variant was not included in the analysis because all information was not available. The analysis was therefore conducted on only five variants, i.e. IIV, VII, IVI, VIV and VVV. Severity of HFMD seemed to correlate with the age of patient (p = 0.011) and the highest severity level was not observed above 11-month old. The VII variant segregated from the other variants on the F1 axis and was associated with both low severity (p = 0.025) and with the ethnicity-2 group, 56.5% of patients from this ethnicity-2 group were infected by the VII variant, but this represented only 46.4% of all samples harboring the VII protein (p = 0.006). No variant was specifically associated with the highest severity (p = 0.99) whereas the IIV variant was correlated with mild severity (p = 0.003).
Spatiotemporal distribution of the virus populations
I/V variants present in the 2011 outbreak belonged mostly the IIV and VII populations which were already present in Northern Vietnam (Fig. 4a) The IIV population was previously detected in 2008 in the Ninh Binh province whereas VII variants were detected in Cao (Fig. 4a) . The VVV variants were not detected in samples collected prior to the 2011-212 outbreak. The mutant populations detected in 2012 were IIV and VII whose prevalence was reduced to 16.2% and 19.3% and VIV and IVI which prevalence rose to 38.7% and 25.8%, respectively (Fig. 4c, d ). The VVV mutant was found only in 2011 in Thanh Hoa, Nam Dinh and Ha Noi (Fig. 4b, d) . With respect to spatial distribution, the rise of variants VII and IIV observed in 2011 was not located in a specific area but covered most of the sampling sites (8 out of 11). The replacement of the IIV and VII variants by the IVI and VIV variants followed a similar pattern confirming the wide-spread diffusion of the outbreak. The number of sites with more than two variants was higher in 2011 than in 2012. The IIV variant was the most widely spread in 2011 but became the least widely spread in 2012 (Fig. 4b, c) . Conversely, the IVI variant which was the least widely spread in 2011 and found in only one province, i.e. Hoa Binh, became the most widely spread in 2012. The VVV variant was found only in 2011 in three (Fig. 4b, c) . could have been slightly more susceptible to the VII and IIV groups. Another explanation might be found in the spatial distribution of the various variant groups, the socio-economic pattern and the route of dissemination. This work was not structured to address this issue and specific sampling schemes as well as transversal analyses should thus be further undertaken. Another main outcome of this work is the observed correlation between I/V variant groups and phylogeny, pathogenicity and ethnicity. One hypothesis is that fixation of mutations in VP1 could be related to the VP1 function itself. Li et al. [16] reported virulent determinants in VP1 located at position 710 and 729 with Glutamic acid, Glycine or Arginine being associated to severe cases at position 710 and Glutamic acid at position 729 being also a marker of severity. In this study we didn't see this correlation with position 710 bearing 90 Glutamic acid, 6 Glycine and 12 Glutamine and position 729 bearing 107 Aspartic acid and 1 Glycine both out of 108 sequences. These amino acids were found in strains associated to mild and moderately severe cases. No highly severe case was found in this work. I/V groups, although based on the relative arrangement of only three amino-acids, overlap the different clusters identified. These clusters correspond to genetically different populations characterized by specific polymorphism traits. This overlap between the specific combination of I/ V residues at three positions and the phylogeny established on the nucleotide sequences suggests the occurrence of a selective pressure on the I/V arrangement. The high conservation of the proteins, despite variability at the nucleotide level, indicative of a negative, or purifying, selection pressure, indicates that the clustering at the protein level is driven by the I/V arrangement. The remaining question is what is the selective pressure acting on I/V variants and what could be the role of these I/V mutations. I/V mutations are located in the VP1 protein at positions 814, 827 and 849 of the polyprotein. The region from amino acid 697 to 862 on the EV-A71 polyprotein at the level of the VP1 protein was shown to be crucial for increasing the strength of protein-protein interactions in the capsid and its stability. This increased stability strongly enhances the pathogenicity and survival of the virus in the gastrointestinal track [15] . Isoleucine and valine are aliphatic hydrophobic amino acid mediating the core structure of the protein and have been reported to be involved in virulence and pathogenicity in several viruses, coxsackievirus B3 [25] , Moloney murne Leukemia Virus [26] , Infectious Bursal Disease virus [32] , Japanese Encephalitis virus [30] , and Simian-Human Immunodeficiency Virus [23] . The recurrent reports of the involvement of isoleucine and valine in the viral pathogenicity process in different viruses as well as their involvement in the selective pressure applied on the EV-A71 isolates analyzed in this work suggest that the I/V pattern at positions 249, 262 and 284 on the VP1 protein might indeed play a role in pathogenicity. The observed correlation of I/V variant populations with severity and ethnicity strengthen this hypothesis. However, the ethnicity correlation could be a result of spatial structuration since ethnicity-2 is mostly present in the Hòa Bình province. This in turn would suggest that the various EV-A71 variants display a geographic specificity.
Conclusion
Altogether, these data suggest that EV-A71 strains could remain in a low level, asymptomatic state, in genomic stasis and with a geographic structuration. The cause for outbreaks should thus be sought for in the socioeconomic patterns rather than in exogenous emergence. Further investigations are needed to investigate this hypothesis and to bring valuable information for the management of this major pediatric disease.
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